Genomic Valley Biotech Limited (BOM:539206)
India flag India · Delayed Price · Currency is INR
31.50
0.00 (0.00%)
At close: Sep 11, 2026

Genomic Valley Biotech Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
96861791066676
Market Cap Growth
-18.58%-52.21%68.80%59.59%-12.12%4.87%
Enterprise Value
96851751066676
Last Close Price
31.5028.0058.5934.7121.7524.75

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
474.74282.2350.26698.3510.25-
PS Ratio
44.6531.9721.2164.232.44107.14
PB Ratio
2.452.184.592.991.882.63
P/TBV Ratio
2.452.184.592.991.882.63
P/FCF Ratio
--1012.58---
P/OCF Ratio
--666.52---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
44.5331.9520.7163.982.44107.03
EV/EBITDA Ratio
282.20195.3439.77694.007.55-
EV/EBIT Ratio
-213.4240.00747.677.62-
EV/FCF Ratio
--988.92---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt / Equity Ratio
-0.01-0.01-0.010.00-0.010.00
Net Debt / EBITDA Ratio
-0.77-0.60-0.10-0.40-0.050.01
Net Debt / FCF Ratio
-1.38-2.560.300.050.00
Asset Turnover
-0.060.190.040.660.01
Quick Ratio
-7.314.933.212.530.08
Current Ratio
-8.415.733.682.895.31
Return on Equity (ROE)
-0.77%9.57%0.43%20.24%-0.25%
Return on Assets (ROA)
-0.58%6.29%0.20%13.25%-5.00%
Return on Invested Capital (ROIC)
0.52%0.78%9.54%0.40%27.35%-10.26%
Return on Capital Employed (ROCE)
-1.00%11.20%0.40%24.70%-12.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
0.21%0.35%1.99%0.14%9.76%-0.12%
FCF Yield
-0.20%-0.22%0.10%-0.19%-11.72%-28.17%
Buyback Yield / Dilution
2.08%0.43%-0.24%0.70%1.79%-1.91%